Patients at high risk of invasive fungal infections: when and how to treat (Q37263189)

19 August 2017

1 reference

title

Patients at high risk of invasive fungal infections: when and how to treat (English)

1 reference

invasive fungal infections

19 August 2017

0 references

1 reference

3

Oliver A Cornely

1 reference

19 August 2017

Jörg Janne Vehreschild

series ordinal

2

object named as

Jörg J Vehreschild

1 reference

19 August 2017

1

Maria J G T Rüping

1 reference

19 August 2017

publication date

1 January 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

68

1 reference

19 August 2017

issue

14

1 reference

19 August 2017

page(s)

1941-1962

1 reference

A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

19 August 2017

cites work

1 reference

12 December 2020

High rate of non-albicans candidemia in Brazilian tertiary care hospitals.

1 reference

12 December 2020

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

1 reference

12 December 2020

Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS.

1 reference

12 December 2020

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

1 reference

12 December 2020

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

1 reference

12 December 2020

Aspergillus Infection of the Burn Wound

1 reference

12 December 2020

Fungal infections in solid-organ transplantation

1 reference

12 December 2020

Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program

1 reference

12 December 2020

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

1 reference

12 December 2020

The epidemiology of hematogenous candidiasis caused by different Candida species

1 reference

12 December 2020

Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients

1 reference

12 December 2020

Infections in liver transplant recipients

1 reference

12 December 2020

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

1 reference

12 December 2020

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

12 December 2020

Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland

1 reference

12 December 2020

Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi‐Institutional Study

1 reference

12 December 2020

Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies

1 reference

12 December 2020

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

1 reference

12 December 2020

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

1 reference

12 December 2020

Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers

1 reference

12 December 2020

Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi

1 reference

12 December 2020

Risk Factors for Invasive Aspergillosis in Solid-Organ Transplant Recipients: A Case-Control Study

1 reference

12 December 2020

Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

1 reference

12 December 2020

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

1 reference

12 December 2020

Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003

1 reference

12 December 2020

Empirical antifungal therapy--new options, new tradeoffs

1 reference

12 December 2020

Anidulafungin versus fluconazole for invasive candidiasis

1 reference

12 December 2020

Fungal burn wound infection. A 10-year experience

1 reference

12 December 2020

Detection of Aspergillus galactomannan by enzyme immunoabsorbent assay in recipients of allogeneic hematopoietic stem cell transplantation: a prospective study

1 reference

12 December 2020

Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole

1 reference

12 December 2020

Management of Candida infections in the adult intensive care unit

1 reference

12 December 2020

Opportunistic fungal infection of the burn wound with phycomycetes and Aspergillus. A clinical-pathologic review

1 reference

12 December 2020

An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.

1 reference

12 December 2020

Treatment of aspergillosis

1 reference

12 December 2020

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

1 reference

12 December 2020

Candidemia: the impact of antifungal prophylaxis in a surgical intensive care unit

1 reference

12 December 2020

Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlle

1 reference

12 December 2020

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

1 reference

12 December 2020

Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey

1 reference

12 December 2020

Impact of current transplantation practices on the changing epidemiology of infections in transplant recipients

1 reference

12 December 2020

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

1 reference

12 December 2020

Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis

1 reference

12 December 2020

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

1 reference

12 December 2020

Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy

1 reference

12 December 2020

Attributable mortality of nosocomial candidemia, revisited

1 reference

12 December 2020

Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies

1 reference

12 December 2020

Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign

1 reference

12 December 2020

Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis

1 reference

12 December 2020

Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of th

1 reference

12 December 2020

A validated clinical approach for the management of aspergillosis in critically ill patients: ready, steady, go!

1 reference

12 December 2020

Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis?

1 reference

12 December 2020

Aspergillus infections in transplant recipients

1 reference

12 December 2020

Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients

1 reference

12 December 2020

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation

1 reference

12 December 2020

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

12 December 2020

Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002.

1 reference

12 December 2020

In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance

1 reference

12 December 2020

Laboratory diagnosis of invasive aspergillosis.

1 reference

12 December 2020

Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy

1 reference

12 December 2020

Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination

1 reference

12 December 2020

Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility.

1 reference

12 December 2020

Risk factors for hospital-acquired candidemia. A matched case-control study

1 reference

12 December 2020

Epidemiology of Candida species infections in critically ill non-immunosuppressed patients

1 reference

12 December 2020

Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients

1 reference

12 December 2020

The epidemiology of candidemia in two United States cities: results of a population-based active surveillance

1 reference

12 December 2020

The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study

1 reference

12 December 2020

Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion test

1 reference

12 December 2020

Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy

1 reference

12 December 2020

Epidemiology of fungal infections in solid organ transplant patients

1 reference

12 December 2020

Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.

1 reference

12 December 2020

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

1 reference

12 December 2020

A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).

1 reference

12 December 2020

Non-bacterial infections in allogeneic non-myeloablative stem cell transplant recipients

1 reference

12 December 2020

Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis

1 reference

12 December 2020

Invasive aspergillosis

1 reference

12 December 2020

Candida colonization and subsequent infections in critically ill surgical patients

1 reference

12 December 2020

Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*.

1 reference

12 December 2020

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

12 December 2020

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group

1 reference

12 December 2020

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

12 December 2020

Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.

1 reference

12 December 2020

The efficacy of itraconazole against systemic fungal infections in neutropenic patients: A randomised comparative study with amphotericin B

1 reference

12 December 2020

Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation

1 reference

12 December 2020

Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

1 reference

12 December 2020

Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients

1 reference

12 December 2020

Epidemiology of invasive candidiasis: a persistent public health problem

1 reference

12 December 2020

European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region

1 reference

12 December 2020

Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients

1 reference

12 December 2020

Current epidemiology of Pneumocystis pneumonia

1 reference

12 December 2020

Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years

1 reference

12 December 2020

Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials

1 reference

12 December 2020

Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients

1 reference

12 December 2020

Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials

1 reference

12 December 2020

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors

1 reference

12 December 2020

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

12 December 2020

Candidemia in Norway (1991 to 2003): results from a nationwide study

1 reference

12 December 2020

A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization

1 reference

12 December 2020

Invasive Candida species infections: a 5 year population-based assessment

1 reference

12 December 2020

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

1 reference

12 December 2020

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

1 reference

12 December 2020

Invasive aspergillosis in the ICU: an emerging disease

1 reference

12 December 2020

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

1 reference

12 December 2020

Prophylactic antifungal therapy in the intensive care unit

1 reference

12 December 2020

In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.

1 reference

12 December 2020

Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000.

1 reference

12 December 2020

Nosocomial Candidemia: An Ounce of Prevention Is Better Than a Pound of Cure

1 reference

12 December 2020

Comparison of caspofungin and amphotericin B for invasive candidiasis

1 reference

12 December 2020

Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study

1 reference

12 December 2020

Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation

1 reference

12 December 2020

Prophylaxis and treatment of invasive candidiasis in the intensive care setting

1 reference

12 December 2020

Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.

1 reference

12 December 2020

Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.

1 reference

12 December 2020

Candidemia in Finland, 1995-1999.

1 reference

12 December 2020

Infection in solid-organ transplant recipients

1 reference

12 December 2020

Invasive aspergillosis in critically ill patients without malignancy

1 reference

12 December 2020

1 reference

12 December 2020

Antifungal prophylaxis for invasive mycoses in high risk patients

1 reference

12 December 2020

Resistance to echinocandin-class antifungal drugs

1 reference

12 December 2020

Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients

1 reference

12 December 2020

Risk factors for invasive aspergillosis in liver transplant recipients

1 reference

12 December 2020

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

1 reference

12 December 2020

Significance of Aspergillus fumigatus isolation from respiratory specimens of nongranulocytopenic patients

1 reference

12 December 2020

Prospective study of Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients

1 reference

12 December 2020

Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials

1 reference

12 December 2020

Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection

1 reference

12 December 2020

Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeits

1 reference

12 December 2020

High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation

1 reference

12 December 2020

Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area

1 reference

12 December 2020

Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management

1 reference

12 December 2020

Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients

1 reference

12 December 2020

Combination antifungal therapy: a critical review of the evidence

1 reference

12 December 2020

Candidemia in French hospitals: incidence rates and characteristics

1 reference

12 December 2020

Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients

1 reference

12 December 2020

Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.

1 reference

12 December 2020

10.2165/00003495-200868140-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

19 August 2017

1052447643

0 references

Fatcat ID

release_7ddyfqoo6jhhrcdexsyrm2k7pe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7ddyfqoo6jhhrcdexsyrm2k7pe

24 November 2022

mapped directly with Wikidata item

1 reference